| REGISTERED NUMBER: 07260218 (England and Wales) |
| GROUP STRATEGIC REPORT, REPORT OF THE DIRECTORS AND |
| CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025 |
| FOR |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED |
| REGISTERED NUMBER: 07260218 (England and Wales) |
| GROUP STRATEGIC REPORT, REPORT OF THE DIRECTORS AND |
| CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025 |
| FOR |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| CONTENTS OF THE CONSOLIDATED FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| Page |
| Company Information | 1 |
| Group Strategic Report | 2 |
| Report of the Directors | 5 |
| Report of the Independent Auditors | 7 |
| Consolidated Income Statement | 11 |
| Consolidated Other Comprehensive Income | 12 |
| Consolidated Balance Sheet | 13 |
| Company Balance Sheet | 14 |
| Consolidated Statement of Changes in Equity | 15 |
| Company Statement of Changes in Equity | 16 |
| Consolidated Cash Flow Statement | 17 |
| Notes to the Consolidated Cash Flow Statement | 18 |
| Notes to the Consolidated Financial Statements | 19 |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED |
| COMPANY INFORMATION |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| DIRECTORS: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| AUDITORS: |
| Chartered Accountants and Statutory Auditors |
| Regent House |
| Bath Avenue |
| Wolverhampton |
| West Midlands |
| WV1 4EG |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| GROUP STRATEGIC REPORT |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| The directors present their strategic report of the company and the group for the year ended 31 December 2025. |
| We aim to present a balanced, comprehensive review of our business's development and performance during the year and its position at year-end. Our review reflects the size and non-complex nature of our business and is written in the context of the risks and uncertainties we face. |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| GROUP STRATEGIC REPORT |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| REVIEW OF BUSINESS |
| Northgate Healthcare provides residential and nursing care homes for the elderly. We currently own and operate five homes across the Midlands. We manage and assess each home individually to ensure performance is measured effectively. |
| We pride ourselves on the quality of our homes and the care we provide. Across our five homes, we provide nursing, specialist dementia and residential care. Nursing care is provided at both Autumn House and Ashcroft Hollow, which also provide specialist dementia and residential care along with our other three homes. |
| As part of our growth strategy, we continue to explore acquisition opportunities. However, during 2025 we were unable to find a suitable acquisition that meets the Northgate ethos. |
| All homes were profitable in 2025 except our newest home, Ashcroft Hollow, which has been undergoing refurbishment when occupancy allows and results in 2026 are positive. The remainder of the homes and the group as a whole are profitable during 2026. Total turnover rose compared with 2024, driven by higher fees and occupancy rates. |
| We have continued the ongoing program of repairs to all homes to ensure they are kept to the high standards we continue to meet for all our service users. This has again resulted in a higher-than-average spend on repairs and maintenance at The Firs and Meadowfields, but it reflects the high standards we endeavour to maintain across the Northgate group. The refurbishment of Autumn House finished in 2025 with the home showing better occupancy as a result. The refurbishment of Ashcroft Hollow was ongoing during the year to ensure the home meets the high standards expected across the Northgate group. We expect overall maintenance expenditure to decrease across the other homes in 2026, apart from the usual cyclical refurbishment programme. We are planning an extension on Ashcroft Hollow for which planning has been granted and this is planned for the latter part of 2026 and 2027. |
| Nursing care is a growing sector within the industry and the directors are satisfied that including this service at both Autumn House and now Ashcroft Hollow is worthwhile to the Northgate Healthcare group. This will ensure Northgate Healthcare can continue to provide residents with the level of care they require as their needs change. |
| Our staff are at the heart of the care we provide and their dedication is central to our success. We recognise that attracting and retaining high-quality staff in the care sector remains a challenge. To support retention, we implemented wage increases in April 2025 and 2026 to remain competitive and to reward staff for their commitment. We also continue to invest in training and professional development to ensure our teams are skilled, motivated and able to deliver the highest standard of care. To ensure staff wellbeing remains a top priority, we offer a health and wellbeing programme for staff employed for over six months. This allows them 24/7 access to a GP and other support networks. This demonstrates our commitment to supporting the staff. |
| We are proud to maintain strong staff retention levels across our homes, which directly contributes to consistency of care, high resident satisfaction, and improved overall performance. By offering career progression, ongoing training and a supportive working environment, we ensure our workforce feels valued and engaged. |
| We consider the key financial performance indicators to be those that communicate the financial performance and strength of the company as a whole, these being average occupancy rates, gross profit margin and earnings before interest, tax, depreciation and amortisation (EBITDA). |
| Occupancy levels improved in 2025 compared with 2024 and we are confident that this trend will continue in 2026, particularly as Ashcroft Hollow continues to build occupancy throughout the year. Resident retention and satisfaction remain high across all homes. |
| The company's gross profit margin is similar to 2024, at 38.96% compared to 39.99% in 2024. This is a testament to both the high standards of the homes and the care provided to our residents. |
| Following the new measures introduced a couple of years ago, and which have continued since, this has helped achieve higher occupancy rates and better profitability across all homes in the group, with both occupancy rates and profitability increasing overall. |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| GROUP STRATEGIC REPORT |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| PRINCIPAL RISKS AND UNCERTAINTIES |
| The company continues to face a few external risks that could impact operations and financial performance, including: |
| - The effects of a further economic downturn, which could lead to further pressures on margins |
| - Changes in the availability of public sector funding, as a proportion of residents rely on government contributions to meet care fees. |
| - Changes to healthcare visas, which could lead to employment shortages throughout the sector. |
| With these risks and uncertainties in mind, we recognise that any plans for the future development of the business may be subject to unforeseen events outside our control. |
| FINANCIAL RISK MANAGEMENT |
| The company's credit risk is low, being primarily attributed to its trade debtors. The company manages all credit risk, both publicly and privately funded, by monitoring payments against contractual agreements. With interest rates continuing to fall during 2025, interest costs have been lower than in 2024, but loans were renegotiated during 2026, so we expect interest costs to fall further in the current year. This has supported profitability for the year and other measures have driven an overall increase in profitability for 2025. The directors continue to manage increased costs to support continued profitability. |
| The company faces financial risk from inflationary pressures on staff costs. Any future changes to the National Living Wage will significantly impact labour costs in the care sector as a whole. The company reviews upcoming changes to the National Living Wage and currently pays above this rate to ensure good quality care staff. The company plans future wage increases to support the company's financial stability and ensure these increases do not overly impact cash flow and profitability. |
| ON BEHALF OF THE BOARD: |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| REPORT OF THE DIRECTORS |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| The directors present their report with the financial statements of the company and the group for the year ended 31 December 2025. |
| DIVIDENDS |
| Interim dividends per share were paid during the year as follows: |
| A Ordinary £1 | - | £5710.56 |
| B Ordinary £1 | - | £9363.20 |
| C Ordinary £1 | - | £4896.89 |
| D Ordinary £1 | - | £12252.60 |
| E Ordinary £1 | - £3675.98 |
| F Ordinary £1 | - £3675.98 |
| The total distribution of dividends for the year ended 31 December 2025 will be £ 681,419 . |
| FUTURE DEVELOPMENTS |
| The directors are confident about the continuing financial performance of the business and continue to seek opportunities to develop the business further. |
| DIRECTORS |
| The directors shown below have held office during the whole of the period from 1 January 2025 to the date of this report. |
| OUR PEOPLE |
| The company provides employees with information on matters of concern to them, consulting them regularly so that their views can be taken into account when making decisions that are likely to affect their interests. |
| Disabled employees |
| The company is committed to a policy of recruitment and promotion based on the basis of aptitude and ability without discrimination of any kind. Particular attention is given to the training and promotion of disabled employees to ensure that their career development is not unfairly restricted by their disability, or perceptions to it. |
| The HR procedures make clear that full and fair consideration must be given to applications made by and the promotion of disabled persons. Where an employee becomes disabled whilst employed by the company, the HR procedures also require that reasonable effort is made to ensure they have the opportunity for continued employment within the company. Retaining of employees who become disabled whilst employed by the company is offered where appropriate. |
| DISCLOSURE IN THE STRATEGIC REPORT |
| A review of the business, principle risks and uncertainties and financial risk management are included in the Strategic Report. |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| REPORT OF THE DIRECTORS |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| STATEMENT OF DIRECTORS' RESPONSIBILITIES |
| The directors are responsible for preparing the Group Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations. |
| Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to: |
| - | select suitable accounting policies and then apply them consistently; |
| - | make judgements and accounting estimates that are reasonable and prudent; |
| - | prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. |
| The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. |
| STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS |
| So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the group's auditors are unaware, and each director has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the group's auditors are aware of that information. |
| AUDITORS |
| The auditors, Muras Baker Jones Limited, will be proposed for re-appointment at the forthcoming Annual General Meeting. |
| ON BEHALF OF THE BOARD: |
| REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED |
| Opinion |
| We have audited the financial statements of Northgate Healthcare Holdings Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 December 2025 which comprise the Consolidated Income Statement, Consolidated Other Comprehensive Income, Consolidated Balance Sheet, Company Balance Sheet, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated Cash Flow Statement and Notes to the Consolidated Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice). |
| In our opinion the financial statements: |
| - | give a true and fair view of the state of the group's and of the parent company affairs as at 31 December 2025 and of the group's profit for the year then ended; |
| - | have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and |
| - | have been prepared in accordance with the requirements of the Companies Act 2006. |
| Basis for opinion |
| We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. |
| Conclusions relating to going concern |
| In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. |
| Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. |
| Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report. |
| Other information |
| The directors are responsible for the other information. The other information comprises the information in the Group Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon. |
| Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. |
| In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. |
| We have nothing to report in this regard. |
| Opinions on other matters prescribed by the Companies Act 2006 |
| In our opinion, based on the work undertaken in the course of the audit: |
| - | the information given in the Group Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and |
| - | the Group Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements. |
| REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED |
| Matters on which we are required to report by exception |
| In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Report of the Directors. |
| We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion: |
| - | adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or |
| - | the parent company financial statements are not in agreement with the accounting records and returns; or |
| - | certain disclosures of directors' remuneration specified by law are not made; or |
| - | we have not received all the information and explanations we require for our audit. |
| Responsibilities of directors |
| As explained more fully in the Statement of Directors' Responsibilities set out on page six, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. |
| In preparing the financial statements, the directors are responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so. |
| REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED |
| Auditors' responsibilities for the audit of the financial statements |
| Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from |
| material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. |
| Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: |
| In planning and designing our audit tests we identify and assess the risks of material misstatement within the financial |
| statements, whether due to fraud or error. Our assessment of these risks includes consideration of the nature of the |
| industry and sector, the control environment and the business performance along with the results of our enquiries of |
| management about their own identification and assessment of risks and irregularities. In common with all audits under ISAs (UK), we are also required to perform specific procedures to respond to the risk of management override. We also obtained an understanding of the legal and regulatory frameworks that the company operates in, focusing on provisions of those laws and regulations that had a direct effect on the determination of material amounts and disclosures in the financial statements. The key laws and regulations we considered in this context included the UK Companies Act, UK tax legislation and other laws and regulations identified as risk areas identified from our discussions with management. |
| We communicated relevant identified laws and regulations and potential fraud risks to all engagement team members including internal specialists, and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit. |
| After consideration of the above risks we then carried out audit procedures including the following: |
| - specific tests in relation to material amounts and disclosures in the financial statements considered to be of high risk; |
| - performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud; |
| - reading minutes of management meetings; |
| - reviewing correspondence with H M Revenue & Customs; |
| - enquiring of management and reviewing any correspondence with legal advisors concerning actual and potential |
| litigation and claims; |
| - reviewing the financial statement disclosures and testing to supporting documentation to assess compliance with |
| provisions of relevant laws and regulations described as having a direct effect on the financial statements; |
| - in addressing the risk of fraud through management override of controls, testing the appropriateness of journal entries and other adjustments; assessing whether the judgements made in making accounting estimates are indicative of a potential bias; and evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business. |
| There are inherent limitations in our audit procedures described above. The more removed that the laws and regulations are from financial transactions the less likely it is that we would be aware on non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any. Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion. |
| A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditor's Report. |
| REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED |
| Use of our report |
| This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed. |
| for and on behalf of |
| Chartered Accountants and Statutory Auditors |
| Regent House |
| Bath Avenue |
| Wolverhampton |
| West Midlands |
| WV1 4EG |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| CONSOLIDATED |
| INCOME STATEMENT |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 2025 | 2024 |
| Notes | £ | £ |
| TURNOVER | 16,304,432 | 13,759,206 |
| Cost of sales | (10,427,602 | ) | (8,316,575 | ) |
| GROSS PROFIT | 5,876,830 | 5,442,631 |
| Administrative expenses | (2,747,559 | ) | (2,486,646 | ) |
| OPERATING PROFIT | 4 | 3,129,271 | 2,955,985 |
| Interest receivable and similar income | 18,373 | 31,650 |
| 3,147,644 | 2,987,635 |
| Interest payable and similar expenses | 5 | (565,381 | ) | (550,930 | ) |
| PROFIT BEFORE TAXATION | 2,582,263 | 2,436,705 |
| Tax on profit | 6 | (652,504 | ) | (661,030 | ) |
| PROFIT FOR THE FINANCIAL YEAR |
| Profit attributable to: |
| Owners of the parent | 1,929,759 | 1,775,675 |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| CONSOLIDATED |
| OTHER COMPREHENSIVE INCOME |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 2025 | 2024 |
| Notes | £ | £ |
| PROFIT FOR THE YEAR | 1,929,759 | 1,775,675 |
| OTHER COMPREHENSIVE INCOME |
| Revaluation surplus | - | (134,975 | ) |
| Income tax relating to other comprehensive income |
- |
- |
| OTHER COMPREHENSIVE INCOME FOR THE YEAR, NET OF INCOME TAX |
- |
(134,975 |
) |
| TOTAL COMPREHENSIVE INCOME FOR THE YEAR |
1,929,759 |
1,640,700 |
| Total comprehensive income attributable to: |
| Owners of the parent | 1,929,759 | 1,640,700 |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| CONSOLIDATED BALANCE SHEET |
| 31 DECEMBER 2025 |
| 2025 | 2024 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Intangible assets | 9 | 1,890,118 | 2,131,406 |
| Tangible assets | 10 | 16,770,120 | 16,628,799 |
| Investments | 11 | - | - |
| 18,660,238 | 18,760,205 |
| CURRENT ASSETS |
| Stocks | 12 | 36,959 | 35,199 |
| Debtors | 13 | 969,205 | 1,080,255 |
| Cash at bank and in hand | 3,111,979 | 2,181,730 |
| 4,118,143 | 3,297,184 |
| CREDITORS |
| Amounts falling due within one year | 14 | 2,673,153 | 2,805,196 |
| NET CURRENT ASSETS | 1,444,990 | 491,988 |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
20,105,228 |
19,252,193 |
| CREDITORS |
| Amounts falling due after more than one year |
15 |
(8,005,284 |
) |
(8,413,745 |
) |
| PROVISIONS FOR LIABILITIES | 19 | (1,995,207 | ) | (1,982,051 | ) |
| NET ASSETS | 10,104,737 | 8,856,397 |
| CAPITAL AND RESERVES |
| Called up share capital | 20 | 120 | 120 |
| Revaluation reserve | 21 | 4,468,122 | 4,468,122 |
| Retained earnings | 21 | 5,636,495 | 4,388,155 |
| SHAREHOLDERS' FUNDS | 10,104,737 | 8,856,397 |
| The financial statements were approved by the Board of Directors and authorised for issue on 10 September 2026 and were signed on its behalf by: |
| A K Haines - Director |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| COMPANY BALANCE SHEET |
| 31 DECEMBER 2025 |
| 2025 | 2024 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Intangible assets | 9 |
| Tangible assets | 10 |
| Investments | 11 |
| CURRENT ASSETS |
| Debtors | 13 |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year | 14 |
| NET CURRENT LIABILITIES | ( |
) | ( |
) |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CREDITORS |
| Amounts falling due after more than one year |
15 |
| NET ASSETS |
| CAPITAL AND RESERVES |
| Called up share capital | 20 |
| Retained earnings | 21 |
| SHAREHOLDERS' FUNDS |
| Company's profit for the financial year | 684,259 | 646,864 |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| CONSOLIDATED STATEMENT OF CHANGES IN EQUITY |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| Called up |
| share | Retained | Revaluation | Total |
| capital | earnings | reserve | equity |
| £ | £ | £ | £ |
| Balance at 1 January 2024 | 120 | 3,259,428 | 4,603,097 | 7,862,645 |
| Changes in equity |
| Dividends | - | (646,948 | ) | - | (646,948 | ) |
| Total comprehensive income | - | 1,775,675 | (134,975 | ) | 1,640,700 |
| Balance at 31 December 2024 | 120 | 4,388,155 | 4,468,122 | 8,856,397 |
| Changes in equity |
| Dividends | - | (681,419 | ) | - | (681,419 | ) |
| Total comprehensive income | - | 1,929,759 | - | 1,929,759 |
| Balance at 31 December 2025 | 120 | 5,636,495 | 4,468,122 | 10,104,737 |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| COMPANY STATEMENT OF CHANGES IN EQUITY |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| Called up |
| share | Retained | Total |
| capital | earnings | equity |
| £ | £ | £ |
| Balance at 1 January 2024 |
| Changes in equity |
| Dividends | - | ( |
) | ( |
) |
| Total comprehensive income | - |
| Balance at 31 December 2024 |
| Changes in equity |
| Dividends | - | ( |
) | ( |
) |
| Total comprehensive income | - |
| Balance at 31 December 2025 |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| CONSOLIDATED CASH FLOW STATEMENT |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 2025 | 2024 |
| Notes | £ | £ |
| Cash flows from operating activities |
| Cash generated from operations | 1 | 3,437,866 | 3,944,291 |
| Interest paid | (552,742 | ) | (538,233 | ) |
| Interest element of hire purchase payments paid |
(12,639 |
) |
(12,697 |
) |
| Tax paid | (877,062 | ) | (589,279 | ) |
| Net cash from operating activities | 1,995,423 | 2,804,082 |
| Cash flows from investing activities |
| Purchase of intangible fixed assets | 58,039 | (2,696,398 | ) |
| Purchase of tangible fixed assets | (389,660 | ) | (155,035 | ) |
| Interest received | 18,373 | 31,650 |
| Net cash from investing activities | (313,248 | ) | (2,819,783 | ) |
| Cash flows from financing activities |
| New loans in year | - | 2,000,000 |
| Loan repayments in year | (452,094 | ) | (347,971 | ) |
| HP capital repayments in year | 81,745 | (30,309 | ) |
| Amount introduced by directors | 300,563 | - |
| Amount withdrawn by directors | (721 | ) | (297,707 | ) |
| Equity dividends paid | (681,419 | ) | (646,948 | ) |
| Net cash from financing activities | (751,926 | ) | 677,065 |
| Increase in cash and cash equivalents | 930,249 | 661,364 |
| Cash and cash equivalents at beginning of year |
2 |
2,181,730 |
1,520,366 |
| Cash and cash equivalents at end of year | 2 | 3,111,979 | 2,181,730 |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| NOTES TO THE CONSOLIDATED CASH FLOW STATEMENT |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 1. | RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS |
| 2025 | 2024 |
| £ | £ |
| Profit before taxation | 2,582,263 | 2,436,705 |
| Depreciation charges | 420,821 | 227,833 |
| Loss on disposal of fixed assets | 55,706 | - |
| Adjustment to purchase price of Leacroft | (44,938 | ) | - |
| Finance costs | 565,381 | 550,930 |
| Finance income | (18,373 | ) | (31,650 | ) |
| 3,560,860 | 3,183,818 |
| Increase in stocks | (1,760 | ) | (7,300 | ) |
| (Increase)/decrease in trade and other debtors | (176,245 | ) | 251,907 |
| Increase in trade and other creditors | 55,011 | 515,866 |
| Cash generated from operations | 3,437,866 | 3,944,291 |
| 2. | CASH AND CASH EQUIVALENTS |
| The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts: |
| Year ended 31 December 2025 |
| 31.12.25 | 1.1.25 |
| £ | £ |
| Cash and cash equivalents | 3,111,979 | 2,181,730 |
| Year ended 31 December 2024 |
| 31.12.24 | 1.1.24 |
| £ | £ |
| Cash and cash equivalents | 2,181,730 | 1,520,366 |
| 3. | ANALYSIS OF CHANGES IN NET DEBT |
| At 1.1.25 | Cash flow | At 31.12.25 |
| £ | £ | £ |
| Net cash |
| Cash at bank and in hand | 2,181,730 | 930,249 | 3,111,979 |
| 2,181,730 | 930,249 | 3,111,979 |
| Debt |
| Finance leases | (159,146 | ) | (81,745 | ) | (240,891 | ) |
| Debts falling due within 1 year | (427,879 | ) | (24,215 | ) | (452,094 | ) |
| Debts falling due after 1 year | (8,282,452 | ) | 476,309 | (7,806,143 | ) |
| (8,869,477 | ) | 370,349 | (8,499,128 | ) |
| Total | (6,687,747 | ) | 1,300,598 | (5,387,149 | ) |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 1. | STATUTORY INFORMATION |
| Northgate Healthcare Holdings Limited is a |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| Related party exemption |
| The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group. |
| Transactions between group entities which have been eliminated on consolidation are not disclosed within the financial statements. |
| Critical accounting judgements and key sources of estimation uncertainty |
| In order to properly apply the company's accounting policies, as described in note 1 above, the directors are required to make judgements and estimates in respect of carrying values of assets and liabilities which may not be apparent from other sources of information. The directors base these critical accounting judgements and estimations on previous historical experience and other factors which the directors judge to be relevant. Judgements and estimates will invariably differ from actual results and hence such judgements and estimates are reviewed by the directors on an ongoing basis. |
| Key sources of estimation uncertainty |
| The key sources of estimation uncertainty which have a significant effect on the amounts recognised in the financial statements are described below: |
| Property valuation |
| The care homes owned by the company have been revalued on a regular basis, the latest of these being based on professional valuations prepared in 2022 on two of the homes with the remaining two being in 2017. These have been reviewed each year by the directors. Although this complies with the relevant accounting standards there is a possibility that the realisable value of the homes may differ to the values used in the event of a sale. |
| Turnover |
| Turnover represents the fees derived from the provision of care services to residents during the year. Income is recognised on a daily basis for the provision of care services. |
| Goodwill |
| Goodwill, being the amount paid in connection with acquisition of care homes in 2007, 2010, 2015 and 2017 is being amortised evenly over its estimated useful economic life of 10 years. In addition goodwill on the purchase of Leacroft Lodge Limited purchased in 2024 is also being amortised evenly over its estimated useful economic life of 10 years. An annual impairment review has been carried out on the carrying value of goodwill and an adjustment is made where necessary. |
| Intangible assets |
| Intellectual property rights and books of account, being the amount paid in connection with the acquisition of a care home in 2010, are is being amortised evenly over its estimated useful economic life of 10 years. An annual impairment review has been carried out on the carrying value and an adjustment is made where necessary. |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 2. | ACCOUNTING POLICIES - continued |
| Tangible fixed assets |
| Fixtures and fittings | - |
| Motor vehicles | - |
| Computer equipment | - |
| Stocks |
| Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. |
| Financial instruments |
| i) Cash and cash Equivalents |
| Cash and cash equivalents are basic financial instruments and include cash in hand, deposits held at call with banks, and bank overdrafts. |
| (ii) Debtors and creditors receivable/payable within one year |
| Debtors and creditors with no stated interest rate and receivable or payable within one year are stated at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses. |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
| Deferred tax |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| Hire purchase and leasing commitments |
| Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter. |
| The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability. |
| Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease. |
| Pension costs and other post-retirement benefits |
| The group operates a defined contribution pension scheme. Contributions payable to the group's pension scheme are charged to profit or loss in the period to which they relate. |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 3. | EMPLOYEES AND DIRECTORS |
| 2025 | 2024 |
| £ | £ |
| Wages and salaries | 8,842,600 | 7,152,643 |
| Social security costs | 730,077 | 494,275 |
| Other pension costs | 276,969 | 222,847 |
| 9,849,646 | 7,869,765 |
| The average number of employees during the year was as follows: |
| 2025 | 2024 |
| Lane House | 47 | 47 |
| The Firs | 99 | 113 |
| Meadowfields | 93 | 89 |
| Autumn House | 110 | 115 |
| Leacroft Lodge | 55 | 51 |
| The average number of employees by undertakings that were proportionately consolidated during the year was 397 (2024 - 415 ) . |
| 2025 | 2024 |
| £ | £ |
| Directors' remuneration | 21,125 | 21,125 |
| Directors' pension contributions to money purchase schemes | 120,000 | 100,000 |
| 4. | OPERATING PROFIT |
| The operating profit is stated after charging: |
| 2025 | 2024 |
| £ | £ |
| Hire of plant and machinery | 66,662 | 61,822 |
| Other operating leases | 6,000 | 5,200 |
| Depreciation - owned assets | 123,736 | 101,341 |
| Depreciation - assets on hire purchase contracts | 68,897 | 41,756 |
| Loss on disposal of fixed assets | 55,706 | - |
| Goodwill amortisation | 228,188 | 84,736 |
| Auditors' remuneration | 27,300 | 11,191 |
| 5. | INTEREST PAYABLE AND SIMILAR EXPENSES |
| 2025 | 2024 |
| £ | £ |
| Bank loan interest | 552,742 | 534,359 |
| Other interest | - | 3,874 |
| Hire purchase | 12,639 | 12,697 |
| 565,381 | 550,930 |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 6. | TAXATION |
| Analysis of the tax charge |
| The tax charge on the profit for the year was as follows: |
| 2025 | 2024 |
| £ | £ |
| Current tax: |
| UK corporation tax | 656,209 | 652,615 |
| Amendment to prior year due to |
| capital allowances claim | (16,861 | ) | - |
| Total current tax | 639,348 | 652,615 |
| Deferred tax | 13,156 | 8,415 |
| Tax on profit | 652,504 | 661,030 |
| Reconciliation of total tax charge included in profit and loss |
| The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below: |
| 2025 | 2024 |
| £ | £ |
| Profit before tax | 2,582,263 | 2,436,705 |
| Profit multiplied by the standard rate of corporation tax in the UK of 25 % (2024 - 25 %) |
645,566 |
609,176 |
| Effects of: |
| Expenses not deductible for tax purposes | 3,621 | 10,245 |
| Capital allowances in excess of depreciation | - | (7,270 | ) |
| Depreciation in excess of capital allowances | 42,374 | - |
| Adjustments to tax charge in respect of previous periods | (16,861 | ) | - |
| Deferred tax movement per note 19 | 13,156 | 8,415 |
| Tax due relating to pre acquisition of subsidiary | (35,352 | ) | 40,464 |
| Total tax charge | 652,504 | 661,030 |
| Tax effects relating to effects of other comprehensive income |
| There were no tax effects for the year ended 31 December 2025. |
| 2024 |
| Gross | Tax | Net |
| £ | £ | £ |
| Revaluation surplus | (134,975 | ) | - | (134,975 | ) |
| 7. | INDIVIDUAL INCOME STATEMENT |
| As permitted by Section 408 of the Companies Act 2006, the Income Statement of the parent company is not presented as part of these financial statements. |
| The parent company's profit for the financial year was £684,259 (2024 - £646,864). |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 8. | DIVIDENDS |
| 2025 | 2024 |
| £ | £ |
| A Ordinary shares of £1 each |
| Interim | 171,316 | 167,948 |
| B Ordinary shares of £1 each |
| Interim | 93,632 | 86,013 |
| C Ordinary shares of £1 each |
| Interim | 146,906 | 147,948 |
| D Ordinary shares of £1 each |
| Interim | 122,526 | 109,000 |
| E Ordinary shares of £1 each |
| Interim | 110,279 | 102,029 |
| F Ordinary shares of £1 each |
| Interim | 36,760 | 34,010 |
| 681,419 | 646,948 |
| 9. | INTANGIBLE FIXED ASSETS |
| Group |
| Patents |
| and |
| Goodwill | licences | Totals |
| £ | £ | £ |
| COST |
| At 1 January 2025 | 3,619,015 | 12,507 | 3,631,522 |
| Other movement | (13,100 | ) | - | (13,100 | ) |
| At 31 December 2025 | 3,605,915 | 12,507 | 3,618,422 |
| AMORTISATION |
| At 1 January 2025 | 1,487,610 | 12,506 | 1,500,116 |
| Amortisation for year | 228,188 | - | 228,188 |
| At 31 December 2025 | 1,715,798 | 12,506 | 1,728,304 |
| NET BOOK VALUE |
| At 31 December 2025 | 1,890,117 | 1 | 1,890,118 |
| At 31 December 2024 | 2,131,405 | 1 | 2,131,406 |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 10. | TANGIBLE FIXED ASSETS |
| Group |
| Fixtures |
| Freehold | and | Motor | Computer |
| property | fittings | vehicles | equipment | Totals |
| £ | £ | £ | £ | £ |
| COST OR VALUATION |
| At 1 January 2025 | 15,761,143 | 2,104,716 | 271,122 | 26,714 | 18,163,695 |
| Additions | 56,284 | 152,795 | 168,818 | 11,764 | 389,661 |
| Disposals | - | (169,877 | ) | - | (10,358 | ) | (180,235 | ) |
| At 31 December 2025 | 15,817,427 | 2,087,634 | 439,940 | 28,120 | 18,373,121 |
| DEPRECIATION |
| At 1 January 2025 | 114,619 | 1,266,043 | 135,864 | 18,370 | 1,534,896 |
| Charge for year | 9,931 | 101,802 | 76,019 | 4,881 | 192,633 |
| Eliminated on disposal | - | (114,754 | ) | - | (9,774 | ) | (124,528 | ) |
| At 31 December 2025 | 124,550 | 1,253,091 | 211,883 | 13,477 | 1,603,001 |
| NET BOOK VALUE |
| At 31 December 2025 | 15,692,877 | 834,543 | 228,057 | 14,643 | 16,770,120 |
| At 31 December 2024 | 15,646,524 | 838,673 | 135,258 | 8,344 | 16,628,799 |
| Cost or valuation at 31 December 2025 is represented by: |
| Fixtures |
| Freehold | and | Motor | Computer |
| property | fittings | vehicles | equipment | Totals |
| £ | £ | £ | £ | £ |
| Valuation in 2010 | 672,989 | - | - | - | 672,989 |
| Valuation in 2013 | 979,584 | - | - | - | 979,584 |
| Valuation in 2016 | 2,271,396 | - | - | - | 2,271,396 |
| Valuation in 2022 | 1,906,817 | - | - | - | 1,906,817 |
| Valuation in 2024 | (163,227 | ) | - | - | - | (163,227 | ) |
| Cost | 10,149,868 | 2,087,634 | 439,940 | 28,120 | 12,705,562 |
| 15,817,427 | 2,087,634 | 439,940 | 28,120 | 18,373,121 |
| If freehold land and buildings had not been revalued they would have been included at the following historical cost: |
| 2025 | 2024 |
| £ | £ |
| Cost | 10,149,868 | 10,093,584 |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 10. | TANGIBLE FIXED ASSETS - continued |
| Group |
| Lane House Residential Care Home and The Firs Residential Care Home were revalued on an open market basis on 1st August 2024 by Colliers International Property Consultants Limited. |
| Meadowfields Residential Care Home and Autumn House Nursing Home were revalued on 7th October 2022 by Colliers International Valuation UK LLP. |
| The freehold properties were valued as fully equipped operational entities, having regard to their trading potential. |
| The property values were reviewed by the Directors as at 31 December 2025. The Directors have many years experience in the care home industry and therefore consider themselves in a proper position to make this review. In their opinion the market value of the all properties above has not materially altered since the date of the independent valuations. |
| Fixed assets, included in the above, which are held under hire purchase contracts are as follows: |
| Motor |
| vehicles |
| £ |
| COST OR VALUATION |
| At 1 January 2025 | 222,702 |
| Additions | 150,318 |
| At 31 December 2025 | 373,020 |
| DEPRECIATION |
| At 1 January 2025 | 97,432 |
| Charge for year | 68,897 |
| At 31 December 2025 | 166,329 |
| NET BOOK VALUE |
| At 31 December 2025 | 206,691 |
| At 31 December 2024 | 125,270 |
| 11. | FIXED ASSET INVESTMENTS |
| Company |
| Shares in |
| group |
| undertakings |
| £ |
| COST |
| At 1 January 2025 |
| Impairments | ( |
) |
| At 31 December 2025 |
| NET BOOK VALUE |
| At 31 December 2025 |
| At 31 December 2024 |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 11. | FIXED ASSET INVESTMENTS - continued |
| The group or the company's investments at the Balance Sheet date in the share capital of companies include the following: |
| Subsidiaries |
| Registered office: White Gables, Cross Lane Head, Bridgnorth WV16 4SJ |
| Nature of business: |
| % |
| Class of shares: | holding |
| 2025 | 2024 |
| £ | £ |
| Aggregate capital and reserves |
| Profit for the year |
| Registered office address is the same as the parent company : White Gables Cross Lane Head Bridgnorth Shropshire WV16 4SJ |
| Registered office: White Gables, Cross Lane Head, Bridgnorth WV16 4SJ |
| Nature of business: |
| % |
| Class of shares: | holding |
| 2025 | 2024 |
| £ | £ |
| Aggregate capital and reserves |
| Registered office address is the same as the parent company : White Gables Cross Lane Head Bridgnorth Shropshire WV16 4SJ |
| Registered office: White Gables, Cross Lane Head, Bridgnorth WV16 4SJ |
| Nature of business: |
| % |
| Class of shares: | holding |
| 2025 | 2024 |
| £ | £ |
| Aggregate capital and reserves |
| (Loss)/profit for the year | ( |
) |
| 12. | STOCKS |
| Group |
| 2025 | 2024 |
| £ | £ |
| Stocks | 36,959 | 35,199 |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 13. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| Group | Company |
| 2025 | 2024 | 2025 | 2024 |
| £ | £ | £ | £ |
| Trade debtors | 929,976 | 720,673 |
| Amounts owed by group undertakings | - | - |
| Other debtors | 20,759 | 17,047 |
| Directors' current accounts | - | 287,295 | - | - |
| Prepayments | 18,470 | 55,240 |
| 969,205 | 1,080,255 |
| 14. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| Group | Company |
| 2025 | 2024 | 2025 | 2024 |
| £ | £ | £ | £ |
| Bank loans and overdrafts (see note 16) | 452,094 | 427,879 |
| Hire purchase contracts (see note 17) | 41,750 | 27,853 |
| Trade creditors | 516,094 | 515,837 |
| Amounts owed to group undertakings | - | - |
| Tax | 255,365 | 493,079 |
| Social security and other taxes | 181,108 | 141,656 |
| Other creditors | 698,293 | 640,740 |
| Directors' current accounts | 13,053 | 506 | - | - |
| Accrued expenses | 515,396 | 557,646 |
| 2,673,153 | 2,805,196 |
| 15. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
| Group | Company |
| 2025 | 2024 | 2025 | 2024 |
| £ | £ | £ | £ |
| Bank loans (see note 16) | 7,806,143 | 8,282,452 |
| Hire purchase contracts (see note 17) | 199,141 | 131,293 |
| 8,005,284 | 8,413,745 |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 16. | LOANS |
| An analysis of the maturity of loans is given below: |
| Group | Company |
| 2025 | 2024 | 2025 | 2024 |
| £ | £ | £ | £ |
| Amounts falling due within one year or on | demand: |
| Bank overdrafts | - | - |
| Bank loans | 452,094 | 427,879 |
| 452,094 | 427,879 |
| Amounts falling due between one and two | years: |
| Bank loans - 1-2 years | 452,094 | 427,879 |
| Amounts falling due between two and five | years: |
| Bank loans - 2-5 years | 5,679,989 | 6,349,997 |
| Amounts falling due in more than five years: |
| Repayable by instalments |
| Bank loans more 5 yr by |
| instalments | 1,674,060 | 1,504,576 | 1,674,060 | 1,504,576 |
| 1,674,060 | 1,504,576 | 1,674,060 | 1,504,576 |
| 17. | LEASING AGREEMENTS |
| Minimum lease payments fall due as follows: |
| Group |
| Hire purchase |
| contracts |
| 2025 | 2024 |
| £ | £ |
| Net obligations repayable: |
| Within one year | 41,750 | 27,853 |
| Between one and five years | 199,141 | 131,293 |
| 240,891 | 159,146 |
| Group |
| Non-cancellable |
| operating leases |
| 2025 | 2024 |
| £ | £ |
| Within one year | 19,904 | 23,667 |
| Between one and five years | 21,562 | 41,466 |
| 41,466 | 65,133 |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 18. | SECURED DEBTS |
| The following secured debts are included within creditors: |
| Group | Company |
| 2025 | 2024 | 2025 | 2024 |
| £ | £ | £ | £ |
| Bank overdrafts | - | - |
| Bank loans | 8,258,237 | 8,710,331 |
| 8,258,237 | 8,710,331 |
| A first legal charge and debenture on freehold property known as Lane House, Lichfield Road, Tamworth, Staffordshire, The Firs, Wodehouse Lane, Sedgley, West Midlands, Meadowfields Residential Care Home, Great Haywood, Stafford and land on the north west and south east side of Pasturefields Lane, Great Haywood, Autumn House and Manor House, Stafford Road, Stone, Ashcroft Hollow, 18A Stafford Road, Huntington, Cannock and all other current and future assets exists in respect of secured debts in favour of National Westminster Bank PLC. |
| 19. | PROVISIONS FOR LIABILITIES |
| Group |
| 2025 | 2024 |
| £ | £ |
| Deferred tax |
| Accelerated capital allowances | 761,115 | 756,560 |
| On revaluation of properties | 1,199,436 | 1,199,436 |
| Deferred tax | 34,656 | 26,055 |
| 1,995,207 | 1,982,051 |
| Group |
| Deferred |
| tax |
| £ |
| Balance at 1 January 2025 | 1,982,051 |
| Accelerated capital allowances | 13,156 |
| Balance at 31 December 2025 | 1,995,207 |
| 20. | CALLED UP SHARE CAPITAL |
| Allotted, issued and fully paid: |
| Number: | Class: | Nominal | 2025 | 2024 |
| value: | £ | £ |
| A Ordinary | £1 | 30 | 30 |
| B Ordinary | £1 | 10 | 10 |
| C Ordinary | £1 | 30 | 30 |
| D Ordinary | £1 | 10 | 10 |
| 30 | E Ordinary | £1 | 30 | 30 |
| 10 | F Ordinary | £1 | 10 | 10 |
| 120 | 120 |
| NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 21. | RESERVES |
| Group |
| Retained | Revaluation |
| earnings | reserve | Totals |
| £ | £ | £ |
| At 1 January 2025 | 4,388,155 | 4,468,122 | 8,856,277 |
| Profit for the year | 1,929,759 | - | 1,929,759 |
| Dividends | (681,419 | ) | - | (681,419 | ) |
| At 31 December 2025 | 5,636,495 | 4,468,122 | 10,104,617 |
| Company |
| Retained |
| earnings |
| £ |
| At 1 January 2025 |
| Profit for the year |
| Dividends | ( |
) |
| At 31 December 2025 |
| The revaluation reserve is solely attributable to the revaluation of freehold property. |
| 22. | RELATED PARTY DISCLOSURES |
| Dividends totalling £681,419 (2024: £646,948) have been declared in respect of shares held by directors and their close family members. |
| 23. | ULTIMATE CONTROLLING PARTY |
| The company is jointly controlled by K Haines, A K Haines and M K Haines. |